0

Journal Articles

in Osteoporosis/Metabolic Bone Disease
 41-60 of 54 Articles
Original Contribution |  March 21, 2001 FREE
Ipriflavone in the Treatment of Postmenopausal Osteoporosis:  A Randomized Controlled Trial
Peter Alexandersen, MD; Anne Toussaint, MD; Claus Christiansen, MD, PhD; et al.
JAMA. 2001;285(11):1482-1488. doi:10.1001/jama.285.11.1482.
Consensus Conference |  February 14, 2001
Osteoporosis Prevention, Diagnosis, and Therapy
NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy
JAMA. 2001;285(6):785-795. doi:10.1001/jama.285.6.785.
The World in Medicine |  November 08, 2000
RVF Strikes the Middle East
JAMA. 2000;284(18):2309. doi:10.1001/jama.284.18.2309.
Medical News and Perspectives |  April 26, 2000
Delay in Treating Schizophrenia May Narrow Therapeutic Window of Opportunity
JAMA. 2000;283(16):2091-2092. doi:10.1001/jama.283.16.2091.
Original Contribution |  March 08, 2000 FREE
Monitoring Osteoporosis Therapy With Bone Densitometry:  Misleading Changes and Regression to the Mean
Steven R. Cummings, MD; Lisa Palermo, MA; Warren Browner, MD; et al.
JAMA. 2000;283(10):1318-1321. doi:10.1001/jama.283.10.1318.
Clinical Crossroads Update |  January 26, 2000
A 73-Year-Old Woman With Osteoporosis, 1 Year Later
Erin E. Hartman, MS; Jennifer Daley, MD
JAMA. 2000;283(4):531. doi:10.1001/jama.283.4.531.
Original Contribution |  October 13, 1999 FREE
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis:  A Randomized Controlled Trial
Steven T. Harris, MD; Nelson B. Watts, MD; Harry K. Genant, MD; et al.
JAMA. 1999;282(14):1344-1352. doi:10.1001/jama.282.14.1344.
The Medical Literature |  August 25, 1999
Users' Guides to the Medical Literature:  XIX. Applying Clinical Trial Results
A. How to Use an Article Measuring the Effect of an Intervention on Surrogate End Points
Heiner C. Bucher, MD, MPH; Gordon H. Guyatt, MD, MSc; Deborah J. Cook, MD, MSc; et al.
JAMA. 1999;282(8):771-778. doi:10.1001/jama.282.8.771.
Editorial |  June 16, 1999
Encouraging News From the SERM Frontier
Adele L. Franks, MD; Karen K. Steinberg, PhD
JAMA. 1999;281(23):2243-2244. doi:10.1001/jama.281.23.2243.
Clinical Crossroads |  April 28, 1999
A 73-Year-Old Woman With Osteoporosis
Susan L. Greenspan, MD
JAMA. 1999;281(16):1531-1540. doi:10.1001/jama.281.16.1531.
Editorial |  December 23, 1998
Bone Mass, Bone Fragility, and the Decision to Treat
Robert P. Heaney, MD
JAMA. 1998;280(24):2119-2120. doi:10.1001/jama.280.24.2119.
Original Contribution |  September 23, 1998 FREE
Prevention of Estrogen Deficiency–Related Bone Loss With Human Parathyroid Hormone–(1-34):  A Randomized Controlled Trial
Joel S. Finkelstein, MD; Anne Klibanski, MD; Amy L. Arnold, BA; et al.
JAMA. 1998;280(12):1067-1073. doi:10.1001/jama.280.12.1067.
The World in Medicine |  April 08, 1998
Safe Motherhood
JAMA. 1998;279(14):1058. doi:10.1001/jama.279.14.1058.
The World in Medicine |  March 11, 1998
From Bird to Boy
JAMA. 1998;279(10):739. doi:10.1001/jama.279.10.739.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Invited Commentary  |  February 4, 2013
Are Calcium Supplements Harmful to Cardiovascular Disease?:  Comment on “ Dietary and Supplemental Calcium Intake and Cardiovascular Diseases Mortality: The National Institutes of Health–AARP Diet and Health Study”
Susanna C. Larsson, PhD
JAMA Ophthalmology
Small Case Series  |  Feb 2013
Squamous Metaplasia of the Conjunctiva:  A Previously Unrecognized Adverse Effect of Risedronate Sodium
Ivayla I. Geneva, BA; Ralph C. Eagle, MD; Ann Barker-Griffith, MD, FRCSC; et al.
JAMA Internal Medicine
Editor's Correspondence  |  Jan 14, 2013
Are Bisphosphonates Associated With an Increased Risk of Atypical Femoral Fractures as a Class?
Michael Pazianas, MD
JAMA Internal Medicine
Original Investigation  |  June 25, 2012
Increasing Occurrence of Atypical Femoral Fractures Associated With Bisphosphonate Use
Raphael P. H. Meier, MD; Thomas V. Perneger, MD; Richard Stern, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems